サワイグループホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/02/26 | 5,995 | 6,046 | 5,793 | 5,820 | -75 | -1.3% | 260,100 |
| 2024/02/22 | 5,984 | 6,004 | 5,880 | 5,895 | -19 | -0.3% | 162,400 |
| 2024/02/21 | 5,956 | 5,966 | 5,865 | 5,914 | -92 | -1.5% | 302,500 |
| 2024/02/20 | 5,962 | 6,146 | 5,920 | 6,006 | +106 | +1.8% | 445,700 |
| 2024/02/19 | 5,752 | 5,915 | 5,716 | 5,900 | +190 | +3.3% | 223,800 |
| 2024/02/16 | 5,945 | 5,945 | 5,647 | 5,710 | -74 | -1.3% | 417,800 |
| 2024/02/15 | 6,120 | 6,127 | 5,764 | 5,784 | -350 | -5.7% | 415,300 |
| 2024/02/14 | 5,871 | 6,345 | 5,773 | 6,134 | +257 | +4.4% | 887,100 |
| 2024/02/13 | 5,817 | 5,912 | 5,774 | 5,877 | +131 | +2.3% | 304,500 |
| 2024/02/09 | 5,680 | 5,746 | 5,673 | 5,746 | +10 | +0.2% | 197,800 |
| 2024/02/08 | 5,695 | 5,790 | 5,662 | 5,736 | +41 | +0.7% | 156,400 |
| 2024/02/07 | 5,700 | 5,775 | 5,678 | 5,695 | -15 | -0.3% | 224,900 |
| 2024/02/06 | 5,700 | 5,775 | 5,690 | 5,710 | +30 | +0.5% | 230,500 |
| 2024/02/05 | 5,761 | 5,768 | 5,680 | 5,680 | -68 | -1.2% | 220,800 |
| 2024/02/02 | 5,799 | 5,832 | 5,725 | 5,748 | +104 | +1.8% | 245,300 |
| 2024/02/01 | 5,599 | 5,698 | 5,599 | 5,644 | +45 | +0.8% | 198,600 |
| 2024/01/31 | 5,575 | 5,650 | 5,547 | 5,599 | +32 | +0.6% | 295,800 |
| 2024/01/30 | 5,595 | 5,606 | 5,547 | 5,567 | -28 | -0.5% | 251,100 |
| 2024/01/29 | 5,668 | 5,731 | 5,570 | 5,595 | -57 | -1% | 269,400 |
| 2024/01/26 | 5,672 | 5,705 | 5,602 | 5,652 | +8 | +0.1% | 301,600 |
| 2024/01/25 | 5,607 | 5,682 | 5,586 | 5,644 | +64 | +1.1% | 338,700 |
| 2024/01/24 | 5,620 | 5,654 | 5,538 | 5,580 | -88 | -1.6% | 253,300 |
| 2024/01/23 | 5,682 | 5,715 | 5,612 | 5,668 | -14 | -0.2% | 370,000 |
| 2024/01/22 | 5,608 | 5,717 | 5,597 | 5,682 | +108 | +1.9% | 275,100 |
| 2024/01/19 | 5,651 | 5,681 | 5,552 | 5,574 | -98 | -1.7% | 348,400 |
| 2024/01/18 | 5,676 | 5,706 | 5,642 | 5,672 | +37 | +0.7% | 375,600 |
| 2024/01/17 | 5,560 | 5,968 | 5,533 | 5,635 | +213 | +3.9% | 883,100 |
| 2024/01/16 | 5,425 | 5,466 | 5,403 | 5,422 | -28 | -0.5% | 200,300 |
| 2024/01/15 | 5,425 | 5,470 | 5,348 | 5,450 | -34 | -0.6% | 222,100 |
| 2024/01/12 | 5,580 | 5,580 | 5,450 | 5,484 | -30 | -0.5% | 305,300 |
| 2024/01/11 | 5,501 | 5,583 | 5,484 | 5,514 | +26 | +0.5% | 251,100 |
| 2024/01/10 | 5,411 | 5,539 | 5,411 | 5,488 | +86 | +1.6% | 227,200 |
| 2024/01/09 | 5,290 | 5,404 | 5,272 | 5,402 | +164 | +3.1% | 203,200 |
| 2024/01/05 | 5,251 | 5,263 | 5,192 | 5,238 | -2 | ±0% | 115,600 |
| 2024/01/04 | 5,201 | 5,247 | 5,104 | 5,240 | +31 | +0.6% | 108,200 |
| 2023/12/29 | 5,194 | 5,227 | 5,152 | 5,209 | +48 | +0.9% | 138,300 |
| 2023/12/28 | 5,149 | 5,187 | 5,107 | 5,161 | +26 | +0.5% | 117,200 |
| 2023/12/27 | 5,049 | 5,150 | 5,030 | 5,135 | +126 | +2.5% | 150,200 |
| 2023/12/26 | 5,142 | 5,148 | 4,980 | 5,009 | -98 | -1.9% | 178,600 |
| 2023/12/25 | 5,042 | 5,127 | 4,982 | 5,107 | +92 | +1.8% | 169,500 |
| 2023/12/22 | 5,035 | 5,051 | 4,988 | 5,015 | +2 | ±0% | 195,000 |
| 2023/12/21 | 4,941 | 5,035 | 4,933 | 5,013 | +44 | +0.9% | 155,700 |
| 2023/12/20 | 4,964 | 4,992 | 4,927 | 4,969 | +49 | +1% | 99,300 |
| 2023/12/19 | 4,999 | 5,023 | 4,740 | 4,920 | -62 | -1.2% | 295,300 |
| 2023/12/18 | 4,951 | 4,999 | 4,895 | 4,982 | +30 | +0.6% | 153,900 |
| 2023/12/15 | 4,884 | 4,978 | 4,882 | 4,952 | +101 | +2.1% | 314,300 |
| 2023/12/14 | 4,906 | 4,939 | 4,840 | 4,851 | -73 | -1.5% | 188,100 |
| 2023/12/13 | 5,001 | 5,016 | 4,909 | 4,924 | -64 | -1.3% | 193,300 |
| 2023/12/12 | 5,030 | 5,073 | 4,986 | 4,988 | -13 | -0.3% | 149,900 |
| 2023/12/11 | 4,959 | 5,045 | 4,951 | 5,001 | +95 | +1.9% | 125,500 |
301～
350
件表示中 / 1010件
類似銘柄と比較する
現在ご覧いただいている「サワイＧＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サワイＧＨＤ | 176,100円 | +5.9% | +24.5% | 3.12% | 11.69倍 | 1.10倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| 日本新薬 | 341,500円 | +8.0% | -15.3% | 3.63% | 9.59倍 | 0.93倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 171,800円 | +5.0% | +1.5% | 0.00% | 14.69倍 | 3.91倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 389,000円 | +3.6% | +6.1% | 3.08% | 13.11倍 | 0.77倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.42倍 | 1.46倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム
